Clinical Trial Update: Biomarker-Driven Pharmacological Treatment of Adolescents With Autism Spectrum Disorder With Gabapentin [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on biomarker-guided gabapentin treatment for adolescents with autism spectrum disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: David Cochran | Conditions: Autism Spectrum Disorder | Phase 4 | Status: COMPLETED